Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
99.72
-1.17 (-1.16%)
At close: Dec 5, 2025, 4:00 PM EST
99.75
+0.03 (0.03%)
After-hours: Dec 5, 2025, 7:42 PM EST
Merck & Co. Employees
As of December 31, 2024, Merck & Co. had 75,000 total employees, including 73,000 full-time and 2,000 part-time employees. The number of employees increased by 3,000 or 4.17% compared to the previous year.
Employees
75,000
Change (1Y)
3,000
Growth (1Y)
4.17%
Revenue / Employee
$856,467
Profits / Employee
$253,787
Market Cap
247.51B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75,000 | 3,000 | 4.17% |
| Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
| Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
| Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
| Dec 31, 2019 | 71,000 | 2,000 | 2.90% |
| Dec 31, 2018 | 69,000 | 0 | - |
| Dec 31, 2017 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2016 | 68,000 | 0 | - |
| Dec 31, 2015 | 68,000 | -2,000 | -2.86% |
| Dec 31, 2014 | 70,000 | -6,000 | -7.89% |
| Dec 31, 2013 | 76,000 | -7,000 | -8.43% |
| Dec 31, 2012 | 83,000 | -3,000 | -3.49% |
| Dec 31, 2011 | 86,000 | -8,000 | -8.51% |
| Dec 31, 2010 | 94,000 | -6,000 | -6.00% |
| Dec 31, 2009 | 100,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| AbbVie | 55,000 |
MRK News
- 3 hours ago - Do These 3 Healthcare Stocks Need a Checkup? - The Motley Fool
- 6 hours ago - Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns - Reuters
- 7 hours ago - Is This Pharmaceutical Giant a Buy After a Major Acquisition? - The Motley Fool
- 16 hours ago - These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? - The Motley Fool
- 1 day ago - Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors - Benzinga
- 1 day ago - FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis) - Business Wire
- 2 days ago - Merck & Co., Inc. (MRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 days ago - Merck & Co., Inc. (MRK) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha